Maria's DKA lecture

    Cards (15)

    • What is DKA
      Affects mostly Type 1, result of total lack of insulin and increase in counter regulatory hormones that allows hepatic FA oxidation in liver to make 3 main ketone body production, leads to ketoacidosis
      • Acetoacetic acid
      • Beta-hydroxybutyric Acid (from reduction of acetoacetic acid, can measure in blood)
      • Acetone (from decarboxylation of acetoacetic acid, can vaporize and gives "acetone" smell associated with DKA)
    • What is HHS
      Mostly type 2, result of relative lack of insulin that causes hyperosmolality, ketones may spill into urine, not enough ketone production to cause ketoacidosis
      • Patient becomes more volume depleted and hyperglycemic
    • Difference between DKA and HHS presentation
      DKA: pt usually presents earlier b/c of sx so less dehydration and glucose not as high (<800, usually 350-450)
      HHS: Greater dehydration d/t osmotic diuresis, high glucose (~1000), ketones in urine, enough insulin to prevent lipolysis
    • DKA patient findings
      Tend to be younger and have better kidney function, RAPID development, neuro sx, abd pain, dehydration, tachycardia, hypotension, hyperventilation (Kussmaul), fruity breath
    • HHS patient findings
      Develop over a longer time period, polyuria/-dipsia, weight loss, neuro sx, dehydration, tachycardia, hypotension
    • Precipitating factors for DKA/HHS
      MI, CVA, sepsis, pancreatitis, glucocorticoids, high dose thiazide diuretics, sympathomimetic agents, atypical antipsychotics, SGLT2 inhibitors, cocaine, MDMA
      • M.C. for DKA: infection, new onset T1DM
      • M.C. for HHS: inadequate insulin tx and noncompliance, infection
    • Initial evaluation for DKA or HHS
      Airway, breathing, circulation, mental status, precipitating events, volume status
    • Labs for DKA or HHS
      glucose, electrolytes (Na, K, creatinine), CBC w/ diff, UA, dipstick, plasma osmolality, beta-hydroxybutyrate, serum ketones, ABG if serum bicarb reduced or hypoxic, EKG
    • DKA lab findings
      Anion gap (>20), K and Na imbalance, high glucose >250, low bicarb (15-18), (+) ketones, variable osmolality
    • HHS lab findings
      K and Na imbalance, very high glucose (>600), >18 serum bicarb, small amount of ketones, very HIGH osmolality (>320)
    • What are the aspects of tx for DKA and HHS
      electrolytes, fluids, insulin, bicarb
    • Electrolyte treatment
      • If K <3.3 = HOLD insulin, 20-40 mEq/L/hr added to IVF until >3.3
      • If K 3.3-5.3 = CAN give insulin, 20-30 added to each L of IVF until 4-5
      • If K >5.3 = CAN give insulin, monitor and replace as needed (NOT w/ IVF), check every 1-2 hours, insulin makes K go into cell
    • Fluid treatment
      Start w/ 0.9 % NS
      • High/normal corrected Na = 0.45% NS
      • Low corrected Na= 0.9 % NS
      • 0.5% dextrose w/ 0.45% NS once glucose up to 200 (DKA) or 300 (HHS)
      IV rate differences
      • Cardiogenic shock = hemodynamic monitor and vasopressors
      • Severe hypovolemia w/o shock or HF = 1 L/hr, 15-20 mL/kg/hr
      • Mild dehydration/hypovolemia = 250-500 mL/hr
    • Insulin treatment
      Rapid or short acting are EQUALLY effective, insulin is the only way to close anion gap
      • Rapid - Lispro (humalog, onset 15-30 mins), Aspart (novolog, onset 10-20 mins)
      • Short - Regular (novolin R, onset 30 mins-1 hr)
      Route can vary
      • If severe - IV bolus (0.1 units/kg) followed y IV infusion (drip, 0.1 units/kg/hr)
      • If mild - subcutaneous insulin
    • Bicarbonate treatment
      Controversial
      • pH > 6.9 = NO bicarb b/c as ketones decrease there will be adequate bicarb available
      • pH < 6.9 = give bicarb
    See similar decks